Hangzhou Minsheng Healthcare Co (SZSE:301507) Debt-to-Equity : 0.00 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Hangzhou Minsheng Healthcare Co Debt-to-Equity?

Hangzhou Minsheng Healthcare Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1.0 Mil. Hangzhou Minsheng Healthcare Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.8 Mil. Hangzhou Minsheng Healthcare Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,531.9 Mil. Hangzhou Minsheng Healthcare Co's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hangzhou Minsheng Healthcare Co's Debt-to-Equity or its related term are showing as below:

During the past 6 years, the highest Debt-to-Equity Ratio of Hangzhou Minsheng Healthcare Co was 0.10. The lowest was 0.00. And the median was 0.01.

SZSE:301507's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Hangzhou Minsheng Healthcare Co Debt-to-Equity Historical Data

The historical data trend for Hangzhou Minsheng Healthcare Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou Minsheng Healthcare Co Debt-to-Equity Chart

Hangzhou Minsheng Healthcare Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.09

0.08

0.01

Hangzhou Minsheng Healthcare Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial									-	0.01	-	-	-

Competitive Comparison of Hangzhou Minsheng Healthcare Co's Debt-to-Equity

For the Drug Manufacturers - General subindustry, Hangzhou Minsheng Healthcare Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hangzhou Minsheng Healthcare Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hangzhou Minsheng Healthcare Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hangzhou Minsheng Healthcare Co's Debt-to-Equity falls into.

Hangzhou Minsheng Healthcare Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hangzhou Minsheng Healthcare Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.045	+	1.085)	/	1473.06
	=	0.00

Hangzhou Minsheng Healthcare Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.045	+	0.843)	/	1531.932
	=	0.00

Hangzhou Minsheng Healthcare Co (SZSE:301507) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Hangzhou Minsheng Healthcare Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Hangzhou Minsheng Healthcare Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hangzhou Minsheng Healthcare Co (SZSE:301507) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hangzhou Minsheng Healthcare Co Ltd (SZSE:301507) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 101, Xintian Road, Donghu Street, Linping, Zhejiang, Hangzhou, CHN, 311100

Website

http://www.21vita.com

Hangzhou Minsheng Healthcare Co Ltd focuses on the field of vitamin and mineral supplements and is a high-tech enterprise integrating research and development, production and sales of vitamin and mineral over-the-counter drugs and health food. The company's current main product is 21 Golden Vita multi-dimensional element tablets (21).

Hangzhou Minsheng Healthcare Co (SZSE:301507) Headlines

No Headlines